Medical cannabis as an alternative therapeutics for Parkinsons' disease: Systematic review.

@article{Bougea2020MedicalCA,
  title={Medical cannabis as an alternative therapeutics for Parkinsons' disease: Systematic review.},
  author={A. Bougea and Christos Koros and A. Simitsi and C. Chrysovitsanou and Athanasios Leonardos and L. Stefanis},
  journal={Complementary therapies in clinical practice},
  year={2020},
  volume={39},
  pages={
          101154
        }
}
OBJECTIVES 1) to evaluate the efficacy of medical cannabinoids (MC) by appraising the quality of evidence from clinical studies 2) to explore the factors hampering the MC use in clinical practice of Parkinson's disease (PD). METHODS We performed a systematic review through various databases. The quality of 14 studies was assessed by Cochrane risk bias (5 randomized controlled trials- RCT) and Newcastle-Ottawa scale (9 uncontrolled studies). RESULTS The positive effects on motor (5 studies… Expand
5 Citations

References

SHOWING 1-10 OF 34 REFERENCES
Cannabis for dyskinesia in Parkinson disease
  • 131
Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
  • 142
  • PDF
Medical Cannabis in Parkinson Disease: Real-Life Patients' Experience
  • 30
  • PDF
Cannabidiol for the treatment of psychosis in Parkinson’s disease
  • 210
The therapeutic potential of cannabinoids for movement disorders
  • 66
Cannabis use in people with Parkinson's disease and Multiple Sclerosis: A web-based investigation.
  • 33
  • PDF
Cannabis and Cardiovascular Disease
  • 8
...
1
2
3
4
...